Sign In
Buy TARS
Tarsus Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -33.06. In total, the insiders bought 847.4K and sold 221.95K TARS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-33.06 |
| ● Buy | 847.4K shares |
| ● Sell | 221.95K shares |
|
59% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 24, 2026 Buy |
Pyott David E I Director |
1 383 Value: $85.0K |
||
|
Apr 24, 2026 Buy |
Pyott David E I Director |
1 383 Value: $85.0K |
||
|
Mar 20, 2026 Sell |
Neervannan Seshadri Chief Operating Officer |
2 989 Value: $199.5K |
||
|
Mar 19, 2026 Sell |
Farrow Jeffrey S See Remarks |
2 186 Value: $146.5K |
||
|
Mar 19, 2026 Sell |
Neervannan Seshadri Chief Operating Officer |
4 589 Value: $307.5K |
||
|
Mar 19, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
4 174 Value: $279.7K |
||
|
Mar 19, 2026 Sell |
Wahl Bryan General Counsel |
4 231 Value: $283.5K |
||
|
Mar 19, 2026 Sell |
Mottiwala Aziz Chief Commercial Officer |
4 440 Value: $297.5K |
||
|
Mar 19, 2026 Sell |
Lin Elizabeth Yeu Chief Medical Officer |
390 Value: $26.1K |
||
|
Mar 19, 2026 Sell |
Azamian Bobak R. President/ceo And Board Chair |
11 964 Value: $801.6K |
||
|
Mar 18, 2026 Sell |
Lin Elizabeth Yeu Chief Medical Officer |
379 Value: $26.0K |
||
|
Mar 18, 2026 Sell |
Neervannan Seshadri Chief Operating Officer |
3 610 Value: $248.0K |
||
|
Mar 18, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
4 071 Value: $279.7K |
||
|
Mar 18, 2026 Sell |
Wahl Bryan General Counsel |
4 125 Value: $283.4K |
||
|
Mar 18, 2026 Sell |
Mottiwala Aziz Chief Commercial Officer |
4 330 Value: $297.5K |
||
|
Mar 18, 2026 Sell |
Farrow Jeffrey S See Remarks |
2 133 Value: $146.6K |
||
|
Mar 18, 2026 Sell |
Azamian Bobak R. President/ceo And Board Chair |
11 667 Value: $801.6K |
||
|
Mar 17, 2026 Sell |
Azamian Bobak R. President/ceo And Board Chair |
10 972 Value: $761.7K |
||
|
Mar 17, 2026 Sell |
Farrow Jeffrey S See Remarks |
2 111 Value: $146.5K |
||
|
Mar 17, 2026 Sell |
Mottiwala Aziz Chief Commercial Officer |
4 286 Value: $297.5K |
||
|
Mar 17, 2026 Sell |
Wahl Bryan General Counsel |
4 084 Value: $283.5K |
||
|
Mar 17, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
4 029 Value: $279.7K |
||
|
Mar 17, 2026 Sell |
Neervannan Seshadri Chief Operating Officer |
3 125 Value: $216.9K |
||
|
Mar 17, 2026 Sell |
Lin Elizabeth Yeu Chief Medical Officer |
375 Value: $26.0K |
||
|
Mar 16, 2026 Sell |
Link William J Phd Director |
3 629 Value: $247.1K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
